Dana Investment Advisors Inc. Increases Position in Pediatrix Medical Group, Inc. $MD

Dana Investment Advisors Inc. lifted its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 5.6% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 801,462 shares of the company’s stock after buying an additional 42,162 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Pediatrix Medical Group were worth $13,424,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Y Intercept Hong Kong Ltd purchased a new position in shares of Pediatrix Medical Group in the 3rd quarter valued at approximately $513,000. Allianz Asset Management GmbH raised its stake in shares of Pediatrix Medical Group by 159.1% during the second quarter. Allianz Asset Management GmbH now owns 61,412 shares of the company’s stock worth $881,000 after purchasing an additional 37,712 shares during the last quarter. Hsbc Holdings PLC lifted its holdings in shares of Pediatrix Medical Group by 226.6% during the second quarter. Hsbc Holdings PLC now owns 111,997 shares of the company’s stock worth $1,591,000 after purchasing an additional 77,704 shares during the period. Edgestream Partners L.P. acquired a new position in Pediatrix Medical Group in the 2nd quarter valued at $763,000. Finally, Wedge Capital Management L L P NC acquired a new position in Pediatrix Medical Group in the 3rd quarter valued at $2,315,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Up 4.8%

Shares of Pediatrix Medical Group stock opened at $19.72 on Tuesday. The company has a 50-day moving average of $21.50 and a two-hundred day moving average of $19.68. Pediatrix Medical Group, Inc. has a 12-month low of $11.84 and a 12-month high of $24.99. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.64 billion, a PE ratio of 10.16 and a beta of 0.76.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Thursday, February 19th. The company reported $0.50 earnings per share for the quarter, missing the consensus estimate of $0.53 by ($0.03). The firm had revenue of $493.77 million during the quarter, compared to analyst estimates of $486.23 million. Pediatrix Medical Group had a net margin of 8.64% and a return on equity of 19.59%. The firm’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period last year, the company posted $0.51 EPS. On average, research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Mark S. Ordan sold 23,000 shares of Pediatrix Medical Group stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $22.41, for a total transaction of $515,430.00. Following the completion of the sale, the chief executive officer directly owned 302,805 shares in the company, valued at $6,785,860.05. The trade was a 7.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

MD has been the subject of a number of analyst reports. Truist Financial cut their price objective on shares of Pediatrix Medical Group from $24.00 to $21.00 and set a “hold” rating for the company in a research report on Thursday. Deutsche Bank Aktiengesellschaft set a $19.00 price target on shares of Pediatrix Medical Group in a report on Friday. UBS Group lifted their price objective on Pediatrix Medical Group from $16.50 to $23.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. Zacks Research downgraded Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 23rd. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Monday, December 29th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $20.00.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.